Genome-wide analysis of somatic noncoding mutation patterns and mitochondrial heteroplasmic shift in type B1 and B2...

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Type B1 and B2 thymomas are lymphocyte-rich tumors with limited known somatic mutations in coding regions.
• The role of noncoding genomic regions in thymoma development remains largely uncharacterized.

Purpose of the Study:

• To investigate the mutation landscape of noncoding regions and mitochondrial DNA in type B1 and B2 thymomas.
• To identify potential functional mutations contributing to thymoma pathogenesis.

Main Methods:

• Developed a method for isolating pure thymoma cells from lymphocyte-rich tissues.
• Performed genome-wide deep sequencing to analyze both nuclear and mitochondrial genomes.
• Systematically analyzed mutations in noncoding cis-regulatory elements and mitochondrial heteroplasmic shifts.

Main Results:

• Noncoding regions exhibited approximately 80 times more somatic mutations than coding regions.
• Identified recurrent mutations in cis-regulatory elements, including IRF8, UBR2, and RNF213.
• Observed tumor-specific/enriched mitochondrial heteroplasmic shifts in 90% of cases, particularly in the D-loop region, suggesting positive selection.

Conclusions:

• Noncoding mutations and mitochondrial heteroplasmic shifts are significant features of type B1 and B2 thymomas.
• These noncoding alterations, alongside mitochondrial changes, may drive thymoma development, especially given the low frequency of coding mutations.
• The findings highlight the importance of exploring the noncoding genome and mitochondrial DNA in cancer research.